wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q53791793-A2DAB662-F3C8-4F05-8B3F-50E99E43CA0E
Q53791793-A2DAB662-F3C8-4F05-8B3F-50E99E43CA0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53791793-A2DAB662-F3C8-4F05-8B3F-50E99E43CA0E
A review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate.
P2860
Q53791793-A2DAB662-F3C8-4F05-8B3F-50E99E43CA0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53791793-A2DAB662-F3C8-4F05-8B3F-50E99E43CA0E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96de2d15b9e85ec6fdd067c946fb6aea923ffd3e
P2860
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.